High dose chemotherapy and autologous hematopoietic stem cell transplantation for rheumatoid arthritis

A number of clinical studies on the effects of high dose chemotherapy (HDC) and autologous stem cell transplantation (ASCT) have demonstrated longterm improvements of disease

In order to compare the reconstitution results of T cell subsets in the synovial tissue in the five responders, flow cytometric analyses of peripheral blood mononuclear cells in the

(a) The T-cell receptor excision circle (TREC) content of total CD4 + T-cells, measured in patients in clinical remission (n = 36, all triangles [Table 1]), is heterogeneous,

Three out of four main dimensions of the generic measure SF-36, except for the dimension of well-being, showed significant improvements in health status scores compared to

Chapter 5 reports the effects of high dose chemotherapy and autologous stem cell transplantation (HDC + ASCT) on j oint damage in patients with severe rheumatoid arthritis

Long term follow-up of health status in patients with severe rheumatoid arthritis after high dose chemotherapy followed by autologous stem

Indien de aan de behandeling gerelateerde mortaliteit minder dan 3.3% is, geniet hoge dosis chemotherapie en autologe hematopoïetische stamcel transplantatie de voorkeur

Autologous stem cell transplantation in juvenile idiopathic arthritis : regaining immunological tolerance and arresting disease progression..